Vaishali Pharma last traded at ₹8.11 (2026-10-13). Over the past month the stock moved -5.4%, three months the stock moved +15.0%, year the stock moved -33.0%. Its closing range over 52 weeks is ₹5.18 – ₹10.23, with the latest close 20.7% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1989, Vaishali Pharma Ltd does marketing of pharmaceutical products including active pharmaceutical ingredients[1]
Business Overview:[1] VPL is certified by ISO 9001:2008 and provides 1500+ products and 250+ Brands including APIs, Formulations, Surgical, Herbals, Veterinary, Nutraceutical, Oncology, and other healthcare products in 35+ locations
In the latest quarter (Jun 2026), Vaishali Pharma reported sales of ₹22.89 crore (-3.6%) and net profit of ₹1.49 crore (+16.4%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 22.89 | 1.49 | 6.51 | 1.49 | 0.11 |
| Mar 2026 | 26.93 | -0.20 | -0.74 | 0.27 | 0.02 |
| Dec 2025 | 24.65 | 1.56 | 6.33 | 1.30 | 0.10 |
| Sep 2025 | 33.45 | 1.39 | 4.16 | 1.18 | 0.09 |
| Jun 2025 | 23.75 | 1.37 | 5.77 | 1.28 | 0.12 |
| Mar 2025 | 32.25 | -6.04 | -18.73 | -4.29 | -0.40 |
| Dec 2024 | 27.91 | 1.36 | 4.87 | 1.44 | 0.13 |
| Sep 2024 | 20.79 | 2.42 | 11.64 | 1.97 | 0.18 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +65.4% | +0.0% | -0.5% | +31.4% | +60.9% | -11.7% | -16.5% | -3.6% |
| Operating profit growth | -8.7% | -53.9% | – | -41.7% | -42.6% | +14.7% | – | +8.8% |
| Net profit growth | +15.9% | -31.8% | – | -24.7% | -40.1% | -9.7% | – | +16.4% |
| EPS growth | +12.5% | -35.0% | – | -25.0% | -50.0% | -23.1% | – | -8.3% |
| OPM % | 11.6% | 4.9% | -18.7% | 5.8% | 4.2% | 6.3% | -0.7% | 6.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Vaishali Pharma reported sales of ₹109.00 crore (+10.1%) and net profit of ₹4.00 crore (+387.8%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 109.00 | 4.00 | 4.00 | 4.00 | 0.31 |
| Mar 2025 | 99.03 | 0.08 | 0.08 | 0.82 | 0.08 |
| Mar 2024 | 86.28 | 1.67 | 1.94 | 0.72 | 0.07 |
| Mar 2023 | 69.66 | 9.38 | 13.47 | 6.60 | 0.63 |
| Mar 2022 | 75.82 | 6.88 | 9.07 | 4.02 | 0.38 |
| Mar 2021 | 53.77 | 2.65 | 4.93 | 1.05 | 0.10 |
| Mar 2020 | 60.09 | 0.91 | 1.51 | 0.03 | 0.00 |
| Mar 2019 | 75.09 | 2.08 | 2.77 | 0.71 | 0.07 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +10.8% | -20.0% | -10.5% | +41.0% | -8.1% | +23.9% | +14.8% | +10.1% |
| Operating profit growth | -25.4% | -56.3% | +191.2% | +159.6% | +36.3% | -82.2% | -95.2% | +4900.0% |
| Net profit growth | -11.3% | -95.8% | +3400.0% | +282.9% | +64.2% | -89.1% | +13.9% | +387.8% |
| EPS growth | -12.5% | -100.0% | – | +280.0% | +65.8% | -88.9% | +14.3% | +287.5% |
| OPM % | 2.8% | 1.5% | 4.9% | 9.1% | 13.5% | 1.9% | 0.1% | 4.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Vaishali Pharma.
Get Free AI Stock Analysis FREE →Stock market today: Gift Nifty hints gap-down start | Vaishali Parekh recommends three stocks to buy today
Stock market today: Gift Nifty hints at a volatile trend | Vaishali Parekh recommends three stocks to buy today
Stock market today: Gift Nifty down | Vaishali Parekh recommends three stocks to buy today
Buy or sell: Gift Nifty signals muted start | Vaishali Parekh recommends three stocks to buy today
Gift Nifty hints big gap-up start | Amid Janmashtami celebrations, Vaishali Parekh recommends three stocks to buy today
Buy or sell: Gift Nifty hints cautious start | Vaishali Parekh recommends three stocks to buy today — 3 September 2026
Buy or sell: Gift Nifty hints cautious start | Vaishali Parekh recommends three stocks to buy today — 3 September 2026
Buy or sell: Gift Nifty signals tepid start | Vaishali Parekh recommends three stocks to buy today -2 September 2026 - TradingView
Buy or sell: Gift Nifty signals tepid start | Vaishali Parekh recommends three stocks to buy today —2 September 2026
Buy or sell: Gift Nifty hits flat opening | Vaishali Parekh recommends three stocks to buy today — 1 September 2026
Vaishali Pharma shares were last quoted at ₹8.11 (+2.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Vaishali Pharma has a price-to-earnings (P/E) ratio of 26.12 and a price-to-book (P/B) ratio of 1.63. The industry P/E is 53.33.
The 52-week high of Vaishali Pharma is ₹12.10 and the 52-week low is ₹4.75.
The market capitalisation of Vaishali Pharma is about ₹116.37 crore.
In the latest quarter (Jun 2026), Vaishali Pharma reported sales of ₹22.89 crore (-3.6%) and net profit of ₹1.49 crore (+16.4%), compared with the same quarter last year.
Promoters hold about 30.54% of Vaishali Pharma.
Vaishali Pharma belongs to the Pharmaceuticals & Drugs sector.